MTOR and neoplasm: Immunotherapeutic approaches using ex vivo cultures for adoptive transfer of genetically modified T-cells including tumor-infiltrating lymphocytes and chimeric antigen receptor-T cells (CAR-T) could also be enhanced by manipulation of mTOR activity.